Related Experiment Videos
Homologous human and murine antisense oligonucleotides targeting stat6. Functional effects on germline cepsilon
S Hill1, E Herlaar, A Le Cardinal
1Molecular and Cell Biology Unit, Novartis Horsham Research Centre, West Sussex, United Kingdom. sandra.hill@pharma.novartis.com
American Journal of Respiratory Cell and Molecular Biology
|November 26, 1999
Summary
Antisense oligonucleotides targeting Signal transducer and activator of transcription 6 (Stat6) effectively inhibit Interleukin (IL)-4 and IL-13 signaling. This approach reduces germline Cepsilon transcription, a key step in immunoglobulin (Ig)E synthesis.
Area of Science:
- Immunology
- Molecular Biology
- Drug Discovery
Background:
- Interleukin (IL)-4 and IL-13 are key cytokines in allergic responses, driving immunoglobulin (Ig)E synthesis.
- This process is mediated by the transcription factor Signal transducer and activator of transcription 6 (Stat6).
- Targeting Stat6 offers a potential therapeutic strategy for allergic diseases.
Purpose of the Study:
- To identify and characterize antisense oligonucleotides (ASOs) targeting Stat6.
- To evaluate the efficacy of ASOs in inhibiting IL-4 and IL-13 signaling pathways.
- To assess the potential of ASOs as an alternative to small molecule inhibitors for Stat6.
Main Methods:
- A gene-walk approach using chemically modified oligonucleotides was employed to find Stat6-targeting sequences.
- Antisense activity was tested in both human and murine models.
- Oligonucleotide 9b was further characterized for its dose-dependent effects on Stat6 mRNA and protein levels via a ribonuclease H-dependent mechanism.
- Impact on germline Cepsilon transcription was assessed in DND39 cells.
Main Results:
- A chimeric oligonucleotide, designated 9b, demonstrated significant antisense activity against both human and murine Stat6.
- Oligonucleotide 9b dose-dependently downregulated Stat6 mRNA and protein.
- The mechanism of action was confirmed to be ribonuclease H-dependent, with no off-target effects on related Stat family members.
- Pretreatment with 9b successfully inhibited IL-4-induced germline Cepsilon transcription in DND39 cells.
Conclusions:
- Antisense oligonucleotides targeting Stat6 are effective in inhibiting IL-4 and IL-13 signaling.
- Oligonucleotide 9b represents a promising candidate for therapeutic intervention.
- ASOs offer a viable alternative to small molecule drugs for modulating Stat6 activity in allergic conditions.